{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:38:09Z","timestamp":1769859489436,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"vor","delay-in-days":247,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"National Institutes of Health-National Institute of Nursing Research Biobehavioral Training","award":["T32NR07106"],"award-info":[{"award-number":["T32NR07106"]}]},{"name":"National Research Service Award","award":["F31NR011124"],"award-info":[{"award-number":["F31NR011124"]}]},{"name":"Achievement Rewards for College Scientists (ARCS) Fellowship, Seattle chapter"},{"name":"Hester McLaw\u2019s Nursing Scholarship Fund"}],"content-domain":{"domain":["clinicalkey.jp","ctr-c.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Communications"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.ctrc.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T11:20:15Z","timestamp":1410348015000},"page":"34-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma"],"prefix":"10.1016","volume":"2","author":[{"given":"Joseph D.","family":"Tariman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardith","family":"Doorenbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen G.","family":"Schepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna L.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrc.2014.08.003_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2407-10-74","article-title":"Trends in the incidence and survival of multiple myeloma in South East England 1985\u20132004","volume":"10","author":"Renshaw","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctrc.2014.08.003_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"25","key":"10.1016\/j.ctrc.2014.08.003_bib3","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ctrc.2014.08.003_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4065\/mcp.2009.0426","article-title":"Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic","volume":"85","author":"Turesson","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"13","key":"10.1016\/j.ctrc.2014.08.003_bib6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1182\/blood-2009-10-163329","article-title":"How I treat elderly patients with myeloma","volume":"116","author":"Mehta","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","article-title":"High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Koreth","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","article-title":"Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321","volume":"24","author":"Barlogie","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib9","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.ctrc.2014.08.003_bib10","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood-2009-08-238196","article-title":"Hematopoietic stem cell transplantation for multiple myeloma beyond 2010","volume":"115","author":"Blade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ctrc.2014.08.003_bib11","unstructured":"P.G. Richardson, J. Wolf, M. Liedtke, S. Lonial, T. Zimmerman, N. Raje, et al., Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-dose Treatment with SCT in MM Patients Up to Age 65 (DFCI 10-106). Info available at: \u3008http:\/\/clinicaltrials.gov\/show\/NCT01208662\u3009, (accessed on 03-25-2014)."},{"key":"10.1016\/j.ctrc.2014.08.003_bib12","unstructured":"National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma. CD-ROM, 2011."},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1078-1439(02)00209-0","article-title":"Treatment decision-making by men with localized prostate cancer: the influence of personal factors","volume":"21","author":"Berry","year":"2003","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.ctrc.2014.08.003_bib14","first-page":"e121","article-title":"Preliminary treatment considerations among men with newly diagnosed prostate cancer","volume":"16","author":"Zeliadt","year":"2010","journal-title":"Am. J. Manag. Care"},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amjsurg.2009.04.005","article-title":"Breast cancer treatment beliefs and influences among surgeons in areas of scientific uncertainty","volume":"199","author":"Schroen","year":"2010","journal-title":"Am. J. Surg."},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1245\/s10434-010-0946-y","article-title":"Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity","volume":"17","author":"Rogers","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.ctrc.2014.08.003_bib17","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1245\/s10434-009-0549-7","article-title":"Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty","volume":"16","author":"Wasif","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.leu.2404516","article-title":"A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy","volume":"21","author":"Stewart","year":"2007","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0025-6196(11)61029-X","article-title":"Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted Therapy (mSMART): consensus statement","volume":"82","author":"Dispenzieri","year":"2007","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.ctrc.2014.08.003_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0609.2010.01431.x","article-title":"Multiple myeloma: chemotherapy or transplantation in the era of new drugs","volume":"84","author":"Palumbo","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.blre.2010.03.001","article-title":"How best to use new therapies in multiple myeloma","volume":"24","author":"Dingli","year":"2010","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MOH.0b013e32832e3154","article-title":"Recent trends in the management of newly diagnosed multiple myeloma","volume":"16","author":"Reece","year":"2009","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.ctrc.2014.08.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488807779316955","article-title":"The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?","volume":"2","author":"Corso","year":"2007","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3816\/CGC.2006.n.040","article-title":"Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer","volume":"5","author":"Berry","year":"2006","journal-title":"Clin. Genitourin. Cancer"},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2354.2003.00409.x","article-title":"Treatment decisions in older patients with colorectal cancer: the role of age and multidimensional function","volume":"12","author":"Bailey","year":"2003","journal-title":"Eur. J. Cancer Care (Engl)"},{"issue":"11","key":"10.1016\/j.ctrc.2014.08.003_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/93.11.850","article-title":"Age and adjuvant chemotherapy use after surgery for stage III colon cancer","volume":"93","author":"Schrag","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1040-8428(02)00133-6","article-title":"Factors influencing treatment patterns of breast cancer patients age 75 and older","volume":"46","author":"Hurria","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.ctrc.2014.08.003_bib28","first-page":"608","article-title":"Adjuvant chemotherapy of breast cancer in the older patient","volume":"24","author":"Taylor","year":"2010","journal-title":"Oncology (Williston Park)"},{"issue":"23","key":"10.1016\/j.ctrc.2014.08.003_bib29","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2010.775","article-title":"Adjuvant chemotherapy use among older patients with stage III colon cancer","volume":"303","author":"Moore","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ctrc.2014.08.003_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.critrevonc.2010.02.010","article-title":"Difficulties in decision making regarding chemotherapy for older cancer patients: a census of cancer physicians","volume":"78","author":"Wan-Chow-Wah","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4 Suppl. 2","key":"10.1016\/j.ctrc.2014.08.003_bib31","first-page":"18","article-title":"Greater risks of chemotherapy toxicity in elderly patients with cancer","volume":"1","author":"Repetto","year":"2003","journal-title":"J. Support. Oncol."},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1040-8428(00)00104-9","article-title":"Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients","volume":"37","author":"Repetto","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1586\/ehm.10.72","article-title":"ESH-SIOG international conference on haematological malignancies in the elderly","volume":"3","author":"Balducci","year":"2010","journal-title":"Expert Rev. Hematol."},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib34","first-page":"135","article-title":"Management of cancer in the elderly","volume":"20","author":"Balducci","year":"2006","journal-title":"Oncology (Williston Park)"},{"issue":"11","key":"10.1016\/j.ctrc.2014.08.003_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3928\/00989134-20061101-05","article-title":"Assessing the stability of values and health care preferences of older adults: a long-term comparison","volume":"32","author":"Martin","year":"2006","journal-title":"J. Gerontol. Nurs."},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.leu.2403289","article-title":"Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome","volume":"18","author":"Sekeres","year":"2004","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.ctrc.2014.08.003_bib37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual. Health Res."},{"issue":"1","key":"10.1016\/j.ctrc.2014.08.003_bib38","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1188\/12.ONF.E70-E83","article-title":"Physician, patient, and contextual factors affecting treatment decisions in older adults with cancer and models of decision making: a literature review","volume":"39","author":"Tariman","year":"2012","journal-title":"Oncol. Nurs. Forum."},{"key":"10.1016\/j.ctrc.2014.08.003_bib39","unstructured":"QSR International Ltd., NVivo 8 Software. Retrieved from: \u3008http:\/\/www.qsrinternational.com\/FileResourceHandler.ashx\/RelatedDocuments\/DocumentFile\/289\/NVivo8-Getting-Started-Guide.pdf\u3009, 2008"},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0011000097254001","article-title":"A guide to conducting consensual qualitative research","volume":"25","author":"Hill","year":"1997","journal-title":"Couns. Psychol."},{"key":"10.1016\/j.ctrc.2014.08.003_bib41","series-title":"Reliability. Content Analysis: An Introduction to its Methodology","first-page":"129","author":"Krippendorff","year":"1980"},{"key":"10.1016\/j.ctrc.2014.08.003_bib42","series-title":"Human Press, Inc","first-page":"297","article-title":"Qualitative research techniques. Clinical Research Methods for Surgeons","author":"Berry","year":"2006"},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/pon.1242","article-title":"Choices in cancer treatment: a qualitative study of the older women\u2019s (>70 years) perspective","volume":"17","author":"Husain","year":"2008","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0090-8258(02)00090-2","article-title":"Women\u2019s perceptions about treatment decision making for ovarian cancer","volume":"88","author":"Elit","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1523-5394.2000.83004.x","article-title":"Patient age and cancer treatment decisions. Patient and physician views","volume":"8","author":"Kutner","year":"2000","journal-title":"Cancer Pract."},{"issue":"4","key":"10.1016\/j.ctrc.2014.08.003_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.beha.2007.09.006","article-title":"Role of autologous stem-cell transplantation in multiple myeloma","volume":"20","author":"Attal","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"19","key":"10.1016\/j.ctrc.2014.08.003_bib47","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ctrc.2014.08.003_bib48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bmt.1705486","article-title":"Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?","volume":"38","author":"Klepin","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib49","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/fampra\/cmg617","article-title":"Who decides about prostate cancer treatment? A qualitative study","volume":"20","author":"Cohen","year":"2003","journal-title":"Fam. Pract."},{"issue":"10","key":"10.1016\/j.ctrc.2014.08.003_bib50","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1200\/JCO.2007.13.5566","article-title":"Physician-identified factors affecting patient participation in reaching treatment decisions","volume":"26","author":"Shepherd","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1207\/s15324796abm3203_6","article-title":"Understanding treatment decision making: contexts, commonalities, complexities, and challenges","volume":"32","author":"Blank","year":"2006","journal-title":"Ann. Behav. Med."},{"issue":"12","key":"10.1016\/j.ctrc.2014.08.003_bib52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/pon.1042","article-title":"A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention","volume":"15","author":"Kreling","year":"2006","journal-title":"Psychooncology"},{"issue":"6","key":"10.1016\/j.ctrc.2014.08.003_bib53","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1634\/theoncologist.2009-0307","article-title":"Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices","volume":"15","author":"Wong","year":"2010","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ctrc.2014.08.003_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/annonc\/mdh044","article-title":"Factors influencing treatment recommendations in early-stage Hodgkin\u2019s disease: a survey of physicians","volume":"15","author":"Ng","year":"2004","journal-title":"Ann. Oncol."},{"issue":"24","key":"10.1016\/j.ctrc.2014.08.003_bib55","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1001\/jama.283.24.3217","article-title":"Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer","volume":"283","author":"Fowler","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ctrc.2014.08.003_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1008392022152","article-title":"Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey","volume":"10","author":"de Jong","year":"1999","journal-title":"Ann. Oncol."}],"container-title":["Cancer Treatment Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213089614000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213089614000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T07:18:52Z","timestamp":1598253532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213089614000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":56,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014]]}},"alternative-id":["S2213089614000073"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrc.2014.08.003","relation":{},"ISSN":["2213-0896"],"issn-type":[{"value":"2213-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrc.2014.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}